07.02.2012
In January, the plant completed delivery of insulin in the regions of around 370 thousand UAH.
20.01.2012
On the pages of some Internet media reported that the plant "Indar" allegedly "working on the remains of raw materials" and domestic production of insulin in general will soon stop.
Solemnly declare that the information of this nature is not true.
17.01.2012
"Indar’s" drugs are manufactured according to international standard GMP, that confirms compliance with the production of international and European standards
Private Joint Stock Company "INDAR" specializing in manufacturing of insulin, is a modern enterprise in the pharmaceutical industry, which manufactures high-quality medicines
It is the only enterprise in Ukraine and fourth in the world to perform full cycle of manufacturing insulin as a medicine.
Manufactures full range of insulin medications - human insulin (semi_synthetic and recombinant) and porcine insulin; medications of other pharmacological groups: peroral sugar-reducing medicines, solutions for infusion; medications that influence blood system and hemopoiesis.
Provides 80% of the Ukrainian market with insulin medications and delevers medications to several countries of the world.